Schizophrenia.com
Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
News
everhopeful
December 13, 2018, 6:35pm
1
6 Likes
everhopeful
December 13, 2018, 7:05pm
2
Firemonkey already posted this. Apologies.
firemonkey
December 13, 2018, 8:40pm
3
It pushed the info up the page so no worries
1 Like
Related topics
Topic
Replies
Views
Activity
Sunovion and PsychoGenics Announce Positive Results from Pivotal Phase 2 Study of Novel Investigational Agent SEP-363856 for the Treatment of Schizophrenia
News
4
423
December 13, 2018
Sunovion and PsychoGenics Initiate DIAMOND Phase 3 Clinical Studies
News
8
482
September 28, 2019
Sunovion Announces Results from Its Open-Label Extension Study of SEP-363856
News
3
369
December 13, 2019
Study Author Q&A: A Novel Antipsychotic Treatment for Schizophrenia -
News
29
958
November 14, 2020
New England Journal of Medicine Publishes Pivotal Results Evaluating Sunovion’s SEP-363856 for the Treatment of Schizophrenia
News
4
443
April 16, 2020